{"id":"granisetron-injection","safety":{"commonSideEffects":[{"rate":"14-21%","effect":"Headache"},{"rate":"3-18%","effect":"Constipation"},{"rate":"5-18%","effect":"Asthenia/fatigue"},{"rate":"3-13%","effect":"Diarrhea"},{"rate":"4-6%","effect":"Abdominal pain"},{"rate":"3-5%","effect":"Fever"}]},"_chembl":{"chemblId":"CHEMBL1237080","moleculeType":"Small molecule","molecularWeight":"348.88"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Granisetron is a selective antagonist of serotonin 5-HT3 receptors, which are located on chemoreceptor trigger zone neurons and on the vagal afferent nerves of the gastrointestinal tract. By blocking these receptors, it prevents the transmission of emetic signals to the vomiting center in the brain, thereby suppressing nausea and vomiting induced by chemotherapy, radiation, or post-operative conditions.","oneSentence":"Granisetron blocks serotonin 5-HT3 receptors on chemoreceptor trigger zone and vagal afferent nerves to prevent nausea and vomiting.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:14:14.831Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of nausea and vomiting induced by chemotherapy"},{"name":"Prevention of post-operative nausea and vomiting"},{"name":"Prevention of radiation-induced nausea and vomiting"}]},"trialDetails":[{"nctId":"NCT07401745","phase":"PHASE4","title":"Occlusal Splint Combined With Granisetron Injection for Management of Myofascial Pain Related to Temporomandibular Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mansoura University","startDate":"2026-01-27","conditions":"TMD, TMD/Orofacial Pain, Temporomandibular Disorder (TMD)","enrollment":48},{"nctId":"NCT04200092","phase":"PHASE1","title":"Staccato® Granisetron Single Dose PK","status":"COMPLETED","sponsor":"Alexza Pharmaceuticals, Inc.","startDate":"2019-11-04","conditions":"Healthy","enrollment":36},{"nctId":"NCT00890565","phase":"PHASE1","title":"Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)","status":"COMPLETED","sponsor":"Kyowa Kirin Co., Ltd.","startDate":"2009-05","conditions":"Healthy","enrollment":240},{"nctId":"NCT00873197","phase":"PHASE1","title":"PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV Granisetron","status":"COMPLETED","sponsor":"Kyowa Kirin Co., Ltd.","startDate":"2009-04","conditions":"Healthy","enrollment":12},{"nctId":"NCT05492669","phase":"PHASE2","title":"Intravenous Lidocaine on Chronic Pain in Patients Undergoing Hepatectomy","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2020-02-27","conditions":"Postoperative Chronic Pain","enrollment":260},{"nctId":"NCT06092944","phase":"NA","title":"Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy","status":"UNKNOWN","sponsor":"Luo Fuchao","startDate":"2023-03-01","conditions":"Esophagus Cancer","enrollment":96},{"nctId":"NCT06031090","phase":"PHASE2","title":"Clonidine Versus Granisetron for Shivering Prevension","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2023-03-05","conditions":"Post Spinal Anesthesia Shivering","enrollment":186},{"nctId":"NCT06000137","phase":"NA","title":"The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy","status":"COMPLETED","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2022-02-10","conditions":"Patient-controlled Analgesia","enrollment":129},{"nctId":"NCT05434663","phase":"PHASE4","title":"Safety Study of Repeat Doses of SUSTOL in Adults","status":"UNKNOWN","sponsor":"Heron Therapeutics","startDate":"2022-07-06","conditions":"Chemotherapy-Induced Nausea and Vomiting (CINV)","enrollment":300},{"nctId":"NCT04295330","phase":"NA","title":"Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2020-02-27","conditions":"Primary Liver Cancer","enrollment":260},{"nctId":"NCT03483870","phase":"PHASE2","title":"Effect of Granisetron on Morphine Induced Pruritus in Cesarean Section","status":"COMPLETED","sponsor":"Assiut University","startDate":"2018-06-01","conditions":"Pruritus","enrollment":80},{"nctId":"NCT02230371","phase":"PHASE4","title":"Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2007-03","conditions":"Myofascial Pain, Temporomandibular Disorders","enrollment":40},{"nctId":"NCT04085393","phase":"PHASE2","title":"Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2020-08-15","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":""},{"nctId":"NCT03434340","phase":"NA","title":"Aromatherapy for Prevention of Intrathecal Morphine Induced Nausea and Vomiting","status":"COMPLETED","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2018-06-26","conditions":"Post Operative Nausea and Vomiting","enrollment":155},{"nctId":"NCT01594749","phase":"PHASE3","title":"Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-09-24","conditions":"Chemotherapy-Induced Nausea and Vomiting (CINV)","enrollment":1015},{"nctId":"NCT00272285","phase":"PHASE3","title":"A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2006-01","conditions":"Vomiting, Nausea","enrollment":287},{"nctId":"NCT02563951","phase":"PHASE1","title":"Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers","status":"COMPLETED","sponsor":"Maxinase Life Sciences Ltd.","startDate":"2015-09","conditions":"Cancer","enrollment":50},{"nctId":"NCT01767714","phase":"PHASE3","title":"Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-04","conditions":"Non-Hodgkin's Lymphoma","enrollment":100},{"nctId":"NCT00359567","phase":"PHASE3","title":"Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy","status":"COMPLETED","sponsor":"Taiho Pharmaceutical Co., Ltd.","startDate":"2006-07","conditions":"Chemotherapy-Induced Nausea and Vomiting","enrollment":1140}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"HYPOAESTHESIA"},{"count":2,"reaction":"DYSPNOEA"},{"count":2,"reaction":"PARAESTHESIA"},{"count":1,"reaction":"ALANINE AMINOTRANSFERASE INCREASED"},{"count":1,"reaction":"ASPARTATE AMINOTRANSFERASE INCREASED"},{"count":1,"reaction":"BLOOD ALKALINE PHOSPHATASE INCREASED"},{"count":1,"reaction":"BLOOD PRESSURE INCREASED"},{"count":1,"reaction":"BONE MARROW FAILURE"},{"count":1,"reaction":"BONE MARROW TRANSPLANT"},{"count":1,"reaction":"COMA"}],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["granisetron"],"phase":"phase_3","status":"active","brandName":"Granisetron Injection","genericName":"Granisetron Injection","companyName":"Eye & ENT Hospital of Fudan University","companyId":"eye-ent-hospital-of-fudan-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Granisetron blocks serotonin 5-HT3 receptors on chemoreceptor trigger zone and vagal afferent nerves to prevent nausea and vomiting. Used for Prevention of nausea and vomiting induced by chemotherapy, Prevention of post-operative nausea and vomiting, Prevention of radiation-induced nausea and vomiting.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}